Related Experiment Video

Updated: Feb 17, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

Rare mutations provide unique insight into oncogenic potential of STAT transcription factors

Lisa N Heppler, David A Frank

    The Journal of Clinical Investigation
    |December 5, 2017
    PubMed

    Insights

    Rare STAT mutations can drive cancer. A new study shows a specific STAT5B mutation (STAT5BN642H) is sufficient to cause T cell cancers in mice, offering insights into STAT5-driven cancer development and treatment.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Cancer Genetics

    Background:

    • Aberrant transcription factor activity, particularly Signal Transducer and Activator of Transcription (STAT) proteins, drives cancer initiation and progression.
    • While constitutive activation of wild-type (WT) STATs is a common oncogenic mechanism, rare STAT mutations are increasingly recognized in hematologic malignancies.
    • The oncogenic potential of specific STAT mutants requires further investigation.

    Purpose of the Study:

    • To investigate the oncogenic potential of STAT5B mutations in T cell malignancies.
    • To determine if a specific STAT5B mutation (STAT5BN642H) is sufficient to induce T cell neoplasia.
    • To provide insights into the pathogenesis of STAT5-driven cancers.

    Main Methods:

    • Utilized a transgenic mouse model to study the effects of STAT5BN642H.
    • Analyzed the development of T cell neoplasia in mice expressing the mutant STAT5B.
    • Correlated findings with existing knowledge of constitutively active STAT mutants.

    Main Results:

    • Demonstrated that the STAT5BN642H mutation is sufficient for the development of T cell neoplasia in a mouse model.
    • Provided direct evidence for the oncogenic capacity of a specific STAT5B mutant.
    • Highlighted the role of STAT mutations in the pathogenesis of hematologic malignancies.

    Conclusions:

    • The STAT5BN642H mutation can act as a driver oncogene in T cell malignancies.
    • Understanding STAT mutant oncogenesis is crucial for developing targeted therapies for STAT5-driven cancers.
    • This research contributes to the broader understanding of transcription factor-driven tumorigenesis.

    More Related Videos

    Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

    Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

    Published on: October 9, 2016

    15.5K
    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome07:23

    Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

    Published on: June 15, 2016

    9.0K

    Related Concept Videos

    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    11.5K
    Cancers Originate from Somatic Mutations in a Single Cell02:21

    Cancers Originate from Somatic Mutations in a Single Cell

    Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
    15.0K
    The Ras Gene02:38

    The Ras Gene

    The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
    Ras is a...
    7.4K
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    4.9K
    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    9.9K
    General Transcription Factors01:30

    General Transcription Factors

    Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
    7.2K